Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29751 - 29775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	NFIX	4784	downregulated	decitabine results in decreased expression of NFIX mRNA	19p13.13	A21913
Decitabine	Approved Investigational	NFKB1	4790	upregulated	decitabine results in increased expression of NFKB1 mRNA	4q24	A21956
Decitabine	Approved Investigational	NFKBIA	4792	upregulated	decitabine results in increased expression of NFKBIA mRNA	14q13.2	A22003 A21912
Decitabine	Approved Investigational	NIPSNAP1	8508	upregulated	decitabine results in increased expression of NIPSNAP1 mRNA	22q12.2	A21917
Decitabine	Approved Investigational	NKX2-1	7080	upregulated	decitabine results in increased expression of NKX2-1 mRNA	14q13.3	A22004
Decitabine	Approved Investigational	NKX2-8	26257	upregulated	decitabine results in increased expression of NKX2-8 mRNA	14q13.3	A21917
Decitabine	Approved Investigational	NKX3-1	4824	upregulated	decitabine results in increased expression of NKX3-1 mRNA	8p21.2	A21923
Decitabine	Approved Investigational	NMB	4828	upregulated	decitabine results in increased expression of NMB mRNA	15q25.2	A21915
Decitabine	Approved Investigational	NNAT	4826	upregulated	decitabine results in increased expression of NNAT mRNA	20q11.23	A22005
Decitabine	Approved Investigational	NOS3	4846	upregulated	decitabine results in increased expression of NOS3 mRNA	7q36.1	A21919
Decitabine	Approved Investigational	NPAS4	266743	upregulated	decitabine results in increased expression of NPAS4 mRNA	11q13.2	A21915
Decitabine	Approved Investigational	NQO1	1728	upregulated	decitabine results in increased expression of NQO1 mRNA	16q22.1	A20985
Decitabine	Approved Investigational	NR1I2	8856	upregulated	decitabine results in increased expression of NR1I2 mRNA	3q13.33	A21911
Decitabine	Approved Investigational	NR2F1	7025	downregulated	decitabine results in decreased expression of NR2F1 mRNA	5q15	A21913
Decitabine	Approved Investigational	NR3C1	2908	downregulated	decitabine results in decreased expression of NR3C1 mRNA alternative form	5q31.3	A22006
Decitabine	Approved Investigational	NR3C1	2908	upregulated	decitabine results in increased expression of NR3C1 mRNA alternative form	5q31.3	A22006
Decitabine	Approved Investigational	NRBP1	29959	upregulated	decitabine results in increased expression of NRBP1 mRNA	2p23.3	A21917
Decitabine	Approved Investigational	NRTN	4902	downregulated	decitabine results in decreased expression of NRTN mRNA	19p13.3	A21913
Decitabine	Approved Investigational	NT5E	4907	upregulated	decitabine results in increased expression of NT5E mRNA	6q14.3	A21919
Decitabine	Approved Investigational	NTRK2	4915	upregulated	decitabine results in increased expression of NTRK2 mRNA	9q21.33	A21912
Decitabine	Approved Investigational	NUBP2	10101	upregulated	decitabine results in increased expression of NUBP2 mRNA	16p13.3	A21917
Decitabine	Approved Investigational	NUMA1	4926	downregulated	decitabine results in decreased expression of NUMA1 mRNA	11q13.4	A21913
Decitabine	Approved Investigational	NXF2	56001	upregulated	decitabine results in increased expression of NXF2 mRNA	Xq22.1	A21955
Decitabine	Approved Investigational	NXPH4	11247	downregulated	decitabine results in decreased expression of NXPH4 mRNA	12q13.3	A21913
Decitabine	Approved Investigational	NXT2	55916	upregulated	decitabine results in increased expression of NXT2 mRNA	Xq23	A20985

Displaying entries 29751 - 29775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability